Clinical Trial Update: Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab with chemotherapy for anaplastic and poorly differentiated thyroid carcinoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Poorly Differentiated Thyroid Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING